Market Overview:
The global phenylalanine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for phenylalanine from various applications such as pharmaceuticals, nutraceuticals, food and others. Phenylalanine is an essential amino acid that plays an important role in human health and is required for normal growth and development. It helps in the production of neurotransmitters such as dopamine and norepinephrine, which are responsible for mood regulation, cognitive function and energy levels. Additionally, it also helps in protein synthesis and supports muscle growth. These factors are expected to drive the demand for phenylalanine over the forecast period. On the basis of type, L-phenylalanine accounted for a major share of the global phenylalanine market in 2017 owing to its high usage across various applications such as pharmaceuticals, nutraceuticals and food products. D-phenylanaline is also used extensively across various application segments; however its use is limited due to its bitter taste which hampers its commercialization potential .
Product Definition:
A non-essential amino acid that is a building block of proteins. It is found in high concentrations in the brain where it is believed to play a role in cognition and mood.
L-Phenylalanine:
L-Phenylalanine, also known as Phe or 4-hydroxy-L-phenylalanine is an amino acid that is naturally produced by the body. It helps to strengthen bones and cartilages, maintain ideal blood pressure levels in the body and acts as a precursor for natural antihistamine production in humans.
D-Phenylalanine:
D-Phenylalanine, also known as DPA or 4-aminobutyl phenol is an intermediate chemical used in the manufacturing of pharmaceutical drugs and other related products. It is a colorless crystalline solid that has a slightly sweet odor. D-Phenylalanine can be manufactured through several routes including hydrolysis of benzene ring, synthesis from bromoacetic acid, and direct oxidation.
Application Insights:
The global phenylalanine market is segmented based on application into pharmaceutical, nutracuetical, food and other applications. The pharmaceutical segment dominated the overall industry in terms of revenue as well as volume in 2017. Phenylalanine has been used for the treatment of brain disorders such as depression since its discovery by Freud et al. during late 19th century and early 20th century (Freudenthal 1907). Moreover, it is also used for the treatment of Parkinson¢â‚¬â„¢s disease (Lundbeck 2009) and attention deficit hyperactivity disorder (ADHD) (Sarafem 2013).
Regional Analysis:
North America was the largest market in 2016 and is expected to maintain its position during the forecast period. The growth of this region can be attributed to rising demand for L-phenylalanine as a result of increasing focus on nutritional products. Moreover, growing awareness regarding mental health coupled with initiatives by government organizations is anticipated to fuel regional product demand. Increasing R&D activities related to drug discovery are also expected to drive phenylalnine market growth over the forecast period.
Asia Pacific is projected to be one of the fastest-growing regions due high production volume and exports from developed countries such as Japan, China, India, Australia among others Phenylalnine Market In Asia Pacific And Middle East & Africa (PAMAEA).
Growth Factors:
- Increasing demand from the pharmaceutical and nutraceutical industries for phenylalanine as a precursor to various drugs and supplements.
- Growing popularity of functional foods and dietary supplements that contain phenylalanine as a health-promoting ingredient.
- Rising incidence of phenylketonuria (PKU), an inherited disorder that results in the inability to break down phenylalanine, driving demand for products containing the amino acid.
- increasing research on the potential health benefits of phenylalanine, including its ability to improve cognitive function, mood, and energy levels.
Scope Of The Report
Report Attributes
Report Details
Report Title
Phenylalalnine Market Research Report
By Type
L-Phenylalanine, D-Phenylalanine, Others
By Application
Pharnaceutical, Nutracuetical, Food, Others
By Companies
Ajinomoto Co., Inc (Japan), CJ Cheil Jedang (South Korea), Kyowa Hakko Bio Co., Ltd. (Japan), Maidan Biology(China), WuxiJinghai Amino Acid Co., Ltd. (China)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Phenylalalnine Market Report Segments:
The global Phenylalalnine market is segmented on the basis of:
Types
L-Phenylalanine, D-Phenylalanine, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharnaceutical, Nutracuetical, Food, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ajinomoto Co., Inc (Japan)
- CJ Cheil Jedang (South Korea)
- Kyowa Hakko Bio Co., Ltd. (Japan)
- Maidan Biology(China)
- WuxiJinghai Amino Acid Co., Ltd. (China)
Highlights of The Phenylalalnine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- L-Phenylalanine
- D-Phenylalanine
- Others
- By Application:
- Pharnaceutical
- Nutracuetical
- Food
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Phenylalalnine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Phenylalnine is a synthetic drug that is used to treat depression and anxiety. It works by increasing the levels of serotonin in the brain.
Some of the key players operating in the phenylalalnine market are Ajinomoto Co., Inc (Japan), CJ Cheil Jedang (South Korea), Kyowa Hakko Bio Co., Ltd. (Japan), Maidan Biology(China), WuxiJinghai Amino Acid Co., Ltd. (China).
The phenylalalnine market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Phenylalalnine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Phenylalalnine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Phenylalalnine Market - Supply Chain
4.5. Global Phenylalalnine Market Forecast
4.5.1. Phenylalalnine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Phenylalalnine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Phenylalalnine Market Absolute $ Opportunity
5. Global Phenylalalnine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Phenylalalnine Market Size and Volume Forecast by Type
5.3.1. L-Phenylalanine
5.3.2. D-Phenylalanine
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Phenylalalnine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Phenylalalnine Market Size and Volume Forecast by Application
6.3.1. Pharnaceutical
6.3.2. Nutracuetical
6.3.3. Food
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Phenylalalnine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Phenylalalnine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Phenylalalnine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Phenylalalnine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Phenylalalnine Demand Share Forecast, 2019-2026
9. North America Phenylalalnine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Phenylalalnine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Phenylalalnine Market Size and Volume Forecast by Application
9.4.1. Pharnaceutical
9.4.2. Nutracuetical
9.4.3. Food
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Phenylalalnine Market Size and Volume Forecast by Type
9.7.1. L-Phenylalanine
9.7.2. D-Phenylalanine
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Phenylalalnine Demand Share Forecast, 2019-2026
10. Latin America Phenylalalnine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Phenylalalnine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Phenylalalnine Market Size and Volume Forecast by Application
10.4.1. Pharnaceutical
10.4.2. Nutracuetical
10.4.3. Food
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Phenylalalnine Market Size and Volume Forecast by Type
10.7.1. L-Phenylalanine
10.7.2. D-Phenylalanine
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Phenylalalnine Demand Share Forecast, 2019-2026
11. Europe Phenylalalnine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Phenylalalnine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Phenylalalnine Market Size and Volume Forecast by Application
11.4.1. Pharnaceutical
11.4.2. Nutracuetical
11.4.3. Food
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Phenylalalnine Market Size and Volume Forecast by Type
11.7.1. L-Phenylalanine
11.7.2. D-Phenylalanine
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysi
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Phenylalalnine Demand Share, 2019-2026
12. Asia Pacific Phenylalalnine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Phenylalalnine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Phenylalalnine Market Size and Volume Forecast by Application
12.4.1. Pharnaceutical
12.4.2. Nutracuetical
12.4.3. Food
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Phenylalalnine Market Size and Volume Forecast by Type
12.7.1. L-Phenylalanine
12.7.2. D-Phenylalanine
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Phenylalalnine Demand Share, 2019-2026
13. Middle East & Africa Phenylalalnine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Phenylalalnine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Phenylalalnine Market Size and Volume Forecast by Application
13.4.1. Pharnaceutical
13.4.2. Nutracuetical
13.4.3. Food
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Phenylalalnine Market Size and Volume Forecast by Type
13.7.1. L-Phenylalanine
13.7.2. D-Phenylalanine
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Phenylalalnine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Phenylalalnine Market: Market Share Analysis
14.2. Phenylalalnine Distributors and Customers
14.3. Phenylalalnine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Ajinomoto Co., Inc (Japan)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. CJ Cheil Jedang (South Korea)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Kyowa Hakko Bio Co., Ltd. (Japan)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Maidan Biology(China)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. WuxiJinghai Amino Acid Co., Ltd. (China)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
